These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 6472373

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Diversity in residual alanine glyoxylate aminotransferase activity in hyperoxaluria type I: correlation with pyridoxine responsiveness.
    Wanders RJ, van Roermund CW, Jurriaans S, Schutgens RB, Tager JM, van den Bosch H, Wolff ED, Przyrembel H, Berger R, Schaaphok FG.
    J Inherit Metab Dis; 1988; 11 Suppl 2():208-11. PubMed ID: 3141704
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Reduction of elevated plasma oxalic acid by pyridoxine therapy in patients on RDT.
    Balcke P, Schmidt P, Zazgornik J, Kopsa H.
    Proc Eur Dial Transplant Assoc; 1983; 19():308-12. PubMed ID: 6878246
    [Abstract] [Full Text] [Related]

  • 8. Successful treatment of infantile type I primary hyperoxaluria complicated by pyridoxine toxicity.
    de Zegher F, Przyrembel H, Chalmers RA, Wolff ED, Huijmans JG.
    Lancet; 1985 Aug 17; 2(8451):392-3. PubMed ID: 2862549
    [No Abstract] [Full Text] [Related]

  • 9. Primary hyperoxaluria: therapeutic strategies for the 90's.
    Scheinman JI.
    Kidney Int; 1991 Sep 17; 40(3):389-99. PubMed ID: 1787639
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Effects of mangesium salts and their combinations with vitamin B6 on oxalates crystalluria in rats fed with pyridoxine-deficient diet].
    Spasov AA, Iezhitsa IN, Kharitonova MV, Kravchenko MS.
    Urologiia; 2009 Sep 17; (3):22-5. PubMed ID: 19670811
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of pyridoxine on sodium glycolate-induced hyperoxaluria in rats.
    Murthy MS, Talwar HS, Thind SK, Nath R.
    Biochem Med; 1981 Aug 17; 26(1):77-84. PubMed ID: 7295305
    [No Abstract] [Full Text] [Related]

  • 17. [Oxalate, oxalic acid].
    Sugimoto T, Kamikawa S, Ishii K.
    Nihon Rinsho; 2004 Nov 17; 62 Suppl 11():689-91. PubMed ID: 15628511
    [No Abstract] [Full Text] [Related]

  • 18. [Oxaluria, nonfamilial hyperoxaluric form of oxalic lithiasis].
    Desgrez P, Thomas J, David-Issartel R.
    J Urol Nephrol (Paris); 1968 Sep 17; 74(9):685-9. PubMed ID: 5718185
    [No Abstract] [Full Text] [Related]

  • 19. [Primary hyperoxaluria type 2(PH2)].
    Ogawa Y, Hatano T.
    Ryoikibetsu Shokogun Shirizu; 1998 Sep 17; (18 Pt 1):395-7. PubMed ID: 9590080
    [No Abstract] [Full Text] [Related]

  • 20. Effect of pyridoxine supplementation on recurrent stone formers.
    Murthy MS, Farooqui S, Talwar HS, Thind SK, Nath R, Rajendran L, Bapna BC.
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep 17; 20(9):434-7. PubMed ID: 7141762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.